Show simple item record

dc.contributor.authorChristaki, Eirinien
dc.contributor.authorOpal, Steven M.en
dc.creatorChristaki, Eirinien
dc.creatorOpal, Steven M.en
dc.date.accessioned2018-06-22T09:52:48Z
dc.date.available2018-06-22T09:52:48Z
dc.date.issued2008
dc.identifier.urihttps://gnosis.library.ucy.ac.cy/handle/7/41514
dc.description.abstractSurvival rates for patients in septic shock have gradually improved in critical care units worldwide over the last 25 years. Further improvement will be predicated on the discovery of new therapies to disrupt the underlying pathophysiology of sepsis and the development of improved rapid, diagnostic testing and immune monitoring of individual patients. © 2008 Wolters Kluwer Health|Lippincott Williams & Wilkins.en
dc.language.isoengen
dc.sourceCurrent opinion in critical careen
dc.subjectUnited statesen
dc.subjectHumanen
dc.subjectPatient careen
dc.subjectHumansen
dc.subjectCancer patienten
dc.subjectQuantitative analysisen
dc.subjectDrug efficacyen
dc.subjectNeutropeniaen
dc.subjectGranulocyte colony stimulating factoren
dc.subjectSurvivalen
dc.subjectSurvival rateen
dc.subjectTreatment outcomeen
dc.subjectReviewen
dc.subjectOutcome assessmenten
dc.subjectAntibiotic agenten
dc.subjectHuman immunodeficiency virus infectionen
dc.subjectImmunosuppressive agenten
dc.subjectMortalityen
dc.subjectImmunoglobulinen
dc.subjectRecombinant erythropoietinen
dc.subjectHypotensionen
dc.subjectHigh risk populationen
dc.subjectDisease severityen
dc.subjectErythrocyte transfusionen
dc.subjectThrombocyte transfusionen
dc.subjectPatient monitoringen
dc.subjectAdrenalinen
dc.subjectPathophysiologyen
dc.subjectKidney functionen
dc.subjectClinical protocolen
dc.subjectInfection risken
dc.subjectArtificial ventilationen
dc.subjectIntensive care uniten
dc.subjectAcute kidney failureen
dc.subjectRenal replacement therapyen
dc.subjectRespiratory failureen
dc.subjectAntibiotic therapyen
dc.subjectSepsisen
dc.subjectSeptic shocken
dc.subjectBacteremiaen
dc.subjectAntibiotic prophylaxisen
dc.subjectAntifungal agenten
dc.subjectAntiinfective agenten
dc.subjectBurnen
dc.subjectCandidiasisen
dc.subjectCatecholamine derivativeen
dc.subjectCatheter removalen
dc.subjectCause of deathen
dc.subjectChild health careen
dc.subjectCritically ill patienten
dc.subjectDopamineen
dc.subjectDrotrecoginen
dc.subjectEpidemiologic studiesen
dc.subjectExtracorporeal oxygenationen
dc.subjectFluid resuscitationen
dc.subjectFungemiaen
dc.subjectGeriatric careen
dc.subjectGlucoseen
dc.subjectGlucose blood levelen
dc.subjectGlycemic controlen
dc.subjectHematopoietic stem cell transplantationen
dc.subjectHemodialysisen
dc.subjectHemodynamicsen
dc.subjectHemofiltrationen
dc.subjectHighly active antiretroviral therapyen
dc.subjectHospital mortalityen
dc.subjectHuman immunodeficiency virus antibodyen
dc.subjectHydrocortisoneen
dc.subjectImmune systemen
dc.subjectInfection preventionen
dc.subjectInjuryen
dc.subjectInotropic agenten
dc.subjectInsulinen
dc.subjectInsulin treatmenten
dc.subjectIntravenous administrationen
dc.subjectNoradrenalinen
dc.subjectNutritional supporten
dc.subjectOpportunistic infectionen
dc.subjectResuscitationen
dc.subjectSepticen
dc.subjectShocken
dc.subjectSurvival ratesen
dc.subjectTissue oxygenationen
dc.subjectVasopressinen
dc.titleIs the mortality rate for septic shock really decreasing?en
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1097/MCC.0b013e32830f1e25
dc.description.volume14
dc.description.issue5
dc.description.startingpage580
dc.description.endingpage586
dc.author.facultyΙατρική Σχολή / Medical School
dc.author.departmentΙατρική Σχολή / Medical School
dc.type.uhtypeArticleen
dc.contributor.orcidChristaki, Eirini [0000-0002-8152-6367]
dc.gnosis.orcid0000-0002-8152-6367


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record